Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study.

@article{Sumiyoshi2010DietaryAO,
  title={Dietary administration of mushroom mycelium extracts in patients with early stage prostate cancers managed expectantly: a phase II study.},
  author={Yoshiteru Sumiyoshi and Katsuyoshi Hashine and Yoshiyuki Kakehi and Koji Yoshimura and Takehumi Satou and Hidetoshi Kuruma and Syunichi Namiki and Nobuo Shinohara},
  journal={Japanese journal of clinical oncology},
  year={2010},
  volume={40 10},
  pages={967-72}
}
OBJECTIVE To assess the efficacy and safety of dietary supplements in patients with early stage prostate cancers who are managed expectantly. METHODS Seventy-four patients with early prostate cancer, who were treated with expectant management, enrolled in the study. A mushroom mycelium extract was given at a dose of 4.5 g/day for 6 months. The primary endpoint was the proportion of patients in which the prostate specific antigen level decreased by 50% or more following treatment. The adverse… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 22 references

Prospective evaluation of selection criteria for active surveillancein Japanese patients with stage T1cN0M0 prostate cancer

Y Kakehi, T Kamoto, +3 authors Y Suzukamo
Jpn. J Clin Oncol2008;38:122–8 • 2008
View 4 Excerpts
Highly Influenced

Guidelines in Oncology

NCCN Clinical Practic
http://www.nccn. org/professionals/physician_gls/f_guidelines.asp (1 February • 2010
View 2 Excerpts

NCCN Clinical Practice Guidelines in Oncology: colon cancer.

Journal of the National Comprehensive Cancer Network : JNCCN • 2009

Similar Papers

Loading similar papers…